ENDO Online 2020 has officially concluded. Thank you to the more than 27,000 researchers and clinicians that joined us for what became the largest online event in our history! Registration is now closed, but recordings of all sessions listed below will remain available on the conference platform until July 6 for those that already signed up.
Time | Session |
---|---|
10:00 – 11:00 AM | The Impact of COVID-19 on Endocrinology Developed in collaboration with the European Society of Endocrinology Chairs: John Newell-Price, MD, PhD, FRCP and Andrea Giustina, MD
Panel Discussion with Faculty Drs. Arlt, Drucker, Guistina, Newell-Price, and Puig-Domingo |
12:00 – 1:30 PM | Improving Outcomes in Acromegaly: Let Patients Be Your Guide |
Time | Session |
---|---|
10:00 – 11:00 AM | Basic Mechanisms in Reproduction: From Beginning to End Chair: Genevieve Scott Neal-Perry, PhD, MD
|
11:00 AM – 12:00 PM | The Many Faces of Diabetes, Obesity, and Metabolism Chair: Kevin Y Lee, PhD
|
12:00 – 1:10 PM (updated) |
Keynote: If We Knew Then What We Know Now, Would We Have Approached The Development of Endocrine Therapies Differently Donald McDonnell, PhD |
1:00 – 2:00 PM | The Many Faces of Nuclear Receptor Biology Chair: Patricia Virginia Elizalde, PhD
|
2:00 – 3:00 PM | From the Brain to the Belly – Insights into Pituitary and Adrenal Physiology Chair: Lori Therese Raetzman, PhD
|
Time | Session |
---|---|
10:00 AM – 12:00 PM | Exhibit Hall Hours |
12:00 – 1:30 PM | Breaking Bad: Reducing Glucose Variability and Increasing Time in Range in Patients with Diabetes |
Time | Session |
---|---|
10:00 AM – 12:00 PM | Exhibit Hall Hours |
12:00 – 1:30 PM | Breaking the Cycle: Approaches to Long-Term Weight Loss and Obesity Care |
Time | Session |
---|---|
10:00 AM – 12:00 PM | Exhibit Hall Hours |
1:00 PM – 1:45 PM | What’s New with ABIM’s Maintenance of Certification? Susan J. Mandel, MD, MPH |
Time | Session |
---|---|
10:00 AM – 12:00 PM | Exhibit Hall Hours |
12:00 – 1:30 PM | Blazing Ahead with Advances in the Management of Adult Growth Hormone Disorder |
Time | Session |
---|---|
10:00 AM – 12:00 PM | Exhibit Hall Hours |
12:00 – 1:00 PM | What Else You Should Know About Resiliency, Communications, Collaborations, and Teaching Strategies: A Live Question and Answer Session with Faculty |
Time | Session |
---|---|
10:00 AM – 12:00 PM | Exhibit Hall Hours |
12:00 – 1:30 PM | Severe Hypoglycemia: The Frequently Forgotten Threat |
Time | Session |
---|---|
12:00 – 1:00 PM | Type One Diabetes Fellows Conference Questions and Answers with the Faculty |
1:00 – 1:30 PM | Device Demonstration by Abbott Diabetes Care, Inc. |
1:30 – 2:00 PM | Device Demonstration by Insulet Corporation |
Time | Session |
---|---|
12:00 – 12:30 PM | Device Demonstration by Medtronic Diabetes |
12:30 – 1:00 PM | Device Demonstration by Dexcom, Inc. |
1:00 – 1:30 PM | Device Demonstration by Tandem Diabetes Care, Inc. |
On-Demand Sessions will be available for you to view at your convenience starting on Monday, June 8 at 11:00 AM following ENDOOnline’s Opening Session, The Impact of COVID-19 on Endocrinology.
Session |
---|
Effective Teaching Strategies Nuha A. El Sayed, MD, MM Sc Mark S. Roberson, PhD |
Resiliency and Managing Burnout Stanley Andrisse, PhD Deborah T. Rana, MSc, MD, FAAP Stuart Slavin, MD, MEd |
Transcending Boundaries: How to Effectively Build Global Networks and Partnerships Diana Cruz Topete, PhD Ana Claudia Latronico, MD, PhD |
Managing Communication Challenges in Science Sally Camper, PhD Cecilia Low-Wang, MD Peter Trainer, MD |
Session |
---|
Controversies in Bariatric Surgery Jenny Tong MD, MPH Marzieh Salehi, MD |
Healthcare of the Transwoman Across the Lifespan Vin Tangpricha MD, PhD |
Moderate to Severe Active Thyroid Eye Disease Chrysoula Dosiou, MD Andrea Kossler, MD |
Pharmacotherapy in Obesity Marc-Andre Cornier, MD David Saxon, MD, MSc |
Type 1 Diabetes Mellitus: From Preconception to Postpartum Elizabeth Buschur, MD |
Session |
---|
Breaking Barriers to Care
|
2020 Endocrine Fellows Series: Type 1 Diabetes Care and Management
|
Telemedicine in the Age of COVID-19 Developed in collaboration with the European Society of Endocrinology Chairs: Gary D. Hammer, MD, PhD and Martin Reincke, MD
|
Primary Prevention of ASCVD and T2DM in Patients at Metabolic Risk: An Endocrine Society Clinical Practice Guideline Moderator: Marie E. McDonnell, MD Task Force Chair: James L. Rosenzweig, MD Panelists: Lars F. Berglund, MD, PhD Marie-France Hivert, MD Rita R. Kalyani, MD |
The Year in Pituitary: Clinical and Research Breakthroughs Mirjam Christ-Crain, MD, PhD |
Session |
---|
Adrenal Medicine – Clinical Applications and New Therapies
|
Challenges in Reproductive Endocrinology: Late Breaking Insights
|
Clinical Challenges in Diabetes and Metabolism
|
Mechanisms and Treatment of Obesity in Humans
|
New Frontiers in Bone and Mineral Metabolism
|
Thyroid Autoimmunity and Benign Thyroid Disease
|
Understanding Pediatric Growth Disorders
|
Product Theater Presentations and Exhibits offer ENDO 2020 Online learners additional educational opportunities. A number of companies will provide a 30-minute focused presentation on the latest products available on the market that clinicians and advanced practice professionals that can impact your practice. Additionally, through the virtual exhibit hall that you can continue your educational journey to learn more about products that can make a difference to your patients.
Product Theaters |
---|
NP Thyroid® (Thyroid Tablets, USP): Understanding the Options for Management of Hypothyroidism For the majority of patients seeking treatment for hypothyroidism and Hashimoto’s thyroiditis, levothyroxine (LT4) monotherapy is the recommended first line treatment. However, many patients remain symptomatic despite achieving normal lab values and thyroid function tests. There is a growing body of clinical evidence that suggests certain subsets of patients with hypothyroidism, such as those with genetic polymorphisms of the D2 deiodinase gene, may benefit from combination therapy with both T4 and T3. This product theater will provide a synopsis of the management of hypothyroidism with combination therapy as well as an overview of NP Thyroid, which is a natural desiccated porcine thyroid extract containing both T4 and T3 indicated for thyroid hormone replacement in hypothyroidism and Hashimoto’s thyroiditis. Presenter: Gary M. Pepper, MD Palm Beach Diabetes & Endocrine Specialists Palm Beach, FL Sponsored by Acella Pharmaceuticals |
The Next Generation of the Guardian™ Connect Continuous Glucose Monitoring System: Accuracy When it Matters Most with Real World Outcomes Introduction to the new Guardian™ Connect CGM app, featuring even more customizable prediction, easier onboarding, and new CareLink™ reports for your practice. Please join us to learn more about the system and the different measures of accuracy, with real world outcomes and case studies demonstrating the integration of CareLink™ reports to help you manage your patients on multiple daily injections. Presenter: Bruce Bode, MD Sponsored by Medtronic |
A Paradigm Shift for the Management of Thyroid Eye Disease (TED) Come learn about the importance of early identification and a new treatment approach for Thyroid Eye Disease (TED) management. This presentation is intended for US-based healthcare professionals. Presenters: Raymond S. Douglas, MD, PhD Professor of Ophthalmology Director, Orbital and Thyroid Eye Disease Center Cedars-Sinai Medical Center, Los Angeles, CA Terry J. Smith, MD Frederick G.L. Huetwell Professor of Ophthalmology and Visual Sciences Professor, Department of Internal Medicine Kellogg Eye Center University of Michigan Medical School, Ann Arbor, MI Sponsored by Horizon Therapeutics |
Enabling Telemedicine and Remote Monitoring with the FreeStyle Libre 14 day System Join us to learn about the #1 CGM worldwide† used by more than 2 million people*, the FreeStyle Libre 14 day system. Daniel Einhorn, M.D., FACP, FACE will share how he utilizes the FreeStyle Libre 14 day system to enable diabetes management and monitoring of patients remotely. He will also share real-world telemedicine patient cases. Presenter: Daniel Einhorn, MD, FACP, FACE Medical Director, Scripps Whittier Diabetes Institute Clinical Professor of Medicine, University of California, San Diego President, Diabetes and Endocrine Associates Disclaimers †Data based on the number of users worldwide for FreeStyle Libre personal CGM compared to the number of users for other leading personal CGM brands. *Data based on the number of users worldwide for FreeStyle Libre products. In the United States product is branded FreeStyle Libre 14 day System. This program is sponsored by Abbott, the speaker or speakers are presenting on behalf of Abbott and the content of the program is in compliance with applicable regulatory requirements. |
Clinical Management of Adrenocortical Carcinoma (ACC) Adrenocortical Carcinoma (ACC) is a rare endocrine tumor with a poor prognosis that requires a multi-disciplinary approach between endocrinologists, oncologists and surgeons. The presentation will focus on the diagnosis, prognosis and current treatment guidelines for ACC patients. Presenter: Mouhammed Amir Habra, MD, F.A.C.P., F.A.C.E. Associate Professor, Deptartment of Endocrine Neoplasia and Hormonal Disorders MD Anderson Cancer Center, Houston, TX Sponsored by HRA Pharma Rare Diseases |
Precision Medicine in Skeletal Dysplasias: Genetics, Pathophysiology, & Investigational Approaches to Therapy More than 400 skeletal dysplasias have a genetic basis of disease identified. Currently, these patients may experience lifelong, progressive, multisystemic comorbidities. This on-demand presentation, moderated by Dr. Ron Rosenfeld, brings together 4 experts who will discuss the genetic basis of skeletal dysplasias, their pathophysiology, and the development of investigational therapies for achondroplasia. Chair and Presenter: Ron Rosenfeld, MD Pediatric Endocrinologist Professor and Chair (emeritus) of Pediatrics Oregon Health and Science University Presenters: Julie Hoover-Fong, MD, PhD Clinical Geneticist Greenberg Center for Skeletal Dysplasias McKusick-Nathans Department of Genetic Medicine Johns Hopkins University, Baltimore, MD Nadia Merchant, MD Pediatric Endocrinologist & Clinical Geneticist Children’s National Hospital, Washington, DC Bradley S. Miller, MD, PhD Professor Division of Endocrinology Department of Pediatrics University of Minnesota Masonic Children’s Hospital, Minneapolis, MN Sponsored by BioMarin Pharmaceuticals |
Finally, an Oral Testosterone Replacement Therapy for Men with Hypogonadism Join us for an overview of an FDA-approved and available oral testosterone replacement therapy. During this program, an expert will discuss the history and challenges of TRTs, and the pathway to approval for this oral option, as well as its safety and efficacy profiles. Presenter: Paresh Dandona MD, PhD State University of New York at Buffalo, Buffalo, New York Sponsored by Clarus Therapeutics |
Product Theater presentations are not part of ENDO Online 2020 official educational programming as planned by the Endocrine Society Program Committee. These events are neither sponsored nor endorsed by the Endocrine Society. These events does not qualify for continuing medical education (CME) credit. |
We know that these are challenging and uncertain times for all of us, our families, and our institutions as we pivot to deal with the realities of COVID-19. We are curating and developing resources that will support our members during this unique time.